PubHawk
February 2012 PMID 21848980

Hyperhidrosis plantaris - a randomized, half-side trial for efficacy and safety of an antiperspirant containing different concentrations of aluminium chloride.

Meike Streker, Tilmann Reuther, Linda Hagen, Martina Kerscher

Full text PDF Download social card

Mentions

4
Peak: 2 in Sep 2021
across 2 sources since Sep 2021

Extended reach

6,367
potential audience

Total likes

128

Video views

6,182

Mentions per month

Sep 2021 – Jul 2025

Where it's discussed

  • X / Twitter2 posts
  • YouTube2 videos

AI synopsis

What people are saying

Several discussions acknowledge the study's promising results, mentioning specific findings such as the efficacy of the 125% aluminium chloride concentration and its safety profile, with words like 'significant reduction' and 'no major side effects' indicating a positive tone. The tone remains informative but modest, reflecting reasonable interest and engagement without extreme enthusiasm or skepticism.

AgreementModerate agreement

Most discussions recognize the validity of the study and its findings, with some highlighting the potential benefits of the tested treatment.

InterestModerate interest

The social discussions show moderate interest, focusing on safety and effectiveness, but do not delve deeply into technical details.

EngagementModerate engagement

Participants show some engagement by referencing the study directly and discussing its implications, but few provide substantial critique or alternative viewpoints.

ImpactNeutral impact

The overall influence on opinion appears moderate, as the discussion suggests recognition of potential treatments but lacks widespread call to action or significant controversy.

Abstract in brief

  • This study tested the safety and effectiveness of a popular treatment for plantar hyperhidrosis, which causes excessive sweating of the feet and can negatively impact social, physical, leisure, and work activities.
  • Both tested concentrations of aluminium chloride (125% and 30%) significantly reduced sweating over 6 weeks, with no major differences in safety or skin irritation, and improvements were observed in sweat tests and patient assessments.
  • Based on the results, the researchers recommend using the 125% concentration for outpatient treatment, as it was both effective and safe for managing hyperhidrosis.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Documents Delivered, LLC
@DocsDel · X

Hyperhidrosis plantaris - a randomized, half-side trial for efficacy and safety of an antiperspirant containing different concentrations of aluminium chloride https://t.co/EKnn2kU8bg

Sep 8, 2021 · 1 share · 178 followers View post →
amnatacharoen
@amnatacharoen · X

RT @DocsDel: Hyperhidrosis plantaris - a randomized, half-side trial for efficacy and safety of an antiperspirant containing different conc…

Sep 8, 2021 · 1 share · 4 followers View post →

All mentions

amnatacharoen
@amnatacharoen · X

RT @DocsDel: Hyperhidrosis plantaris - a randomized, half-side trial for efficacy and safety of an antiperspirant containing different conc…

Sep 8, 2021 · 1 share · 4 followers View post →
Documents Delivered, LLC
@DocsDel · X

Hyperhidrosis plantaris - a randomized, half-side trial for efficacy and safety of an antiperspirant containing different concentrations of aluminium chloride https://t.co/EKnn2kU8bg

Sep 8, 2021 · 1 share · 178 followers View post →